Streetbeat News

Stock Prices

BHP

Benzinga's options scanner detected significant options activity on BHP Group (NYSE:BHP), with over 8 transactions totaling $641,935. Whales target a price range of $55.0 to $77.5 for BHP over the next 3 months. The volume and open interest trends suggest liquidity and interest in BHP's options. BHP is a global miner, recently acquiring Oz Minerals and entering the potash market. BHP's stock is slightly down with a potential oversold RSI, and earnings are expected in 39 days.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 7:31 pm

EOG

EOG Resources (NYSE:EOG) has delivered an average annual return of 12.12% over the past 20 years, outperforming the market. A $1000 investment in EOG 20 years ago would be worth $9,849.32 today. The company's current market capitalization stands at $67.29 billion.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 7:30 pm

LNT

Alliant Energy's stock (LNT) trades lower following a downgrade by BMO Capital from Outperform to Market Perform.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 7:28 pm

ALB

Albemarle Corporation's stock (ALB) is trading lower after Deutsche Bank downgraded the stock from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 7:27 pm

GBTC

Grayscale Investments, led by CEO Michael Sonnenshein, intends to file for a covered call ETF that will allow investors to earn income from options on its Grayscale Bitcoin Trust (GBTC).

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 7:26 pm

SPY

Fed's Barkin has stated that he will not prejudge the outcome of the March FOMC meeting or other future meetings. He also mentioned that inflation expectations do not seem elevated at this point, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 7:23 pm

SPY

Fed's Barkin has noted encouraging progress in the goods sector, suggesting it may continue. He also mentioned that some service sector businesses have discovered pricing power, which they are likely to maintain until faced with consumer or competitor pushback.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 7:23 pm

CYTK

NVS

Novartis AG (NYSE:NVS) has decided not to pursue the acquisition of Cytokinetics Inc (NASDAQ:CYTK), a developer of a promising heart-drug. This decision has impacted Cytokinetics' stock, which fell 21.40%. Cytokinetics is considering other options, including a capital raise. Novartis is looking for growth opportunities but is focusing on acquisitions under $5 billion, as stated by CEO Vasant Narasimhan.

Portfolio Pulse from Vandana Singh

January 11, 2024 | 7:22 pm

DCGO

DocGo Inc (NASDAQ:DCGO) responded to a short report by Fuzzy Panda, which accused the company of fraudulent billing and other illegal practices. DocGo refuted the claims, asserting its fiscal health and growth plans, with preliminary FY 2023 revenue of $615-$625 million and an expected increase in 2024 revenue to exceed $700 million. Needham maintained a Buy rating on DCGO with a $14 price target. DCGO shares rose 10.40% to $3.30 after the response.

Portfolio Pulse from Vandana Singh

January 11, 2024 | 7:15 pm